If you are a subscriber, please Log In.
Cabot Profit Booster 125
May 27, 2020
This biopharmaceutical firm acquires, rebrands and reprices drugs for sale in the U.S., with many that treat inflammatory conditions, including a few that take aim at rare diseases.
May 14, 2020
Tomorrow is the expiration of May options, and it's been a spectacular month for our covered call strategy. View Update Archive